EVP, Chief Scientific Officer of Ionis Pharmaceuticals Inc (30-Year Financial, Insider Trades) C Frank Bennett (insider trades) sold 15,000 shares of IONS on 06/25/2020 at an average price of $59.77 a share. The total sale was $896,550.
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis Pharmaceuticals Inc has a market cap of $8.28 billion; its shares were traded at around $59.40 with a P/E ratio of 54.01 and P/S ratio of 8.80. GuruFocus has detected 1 severe warning sign with Ionis Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- Director Breaux Castleman sold 10,000 shares of IONS stock on 06/25/2020 at the average price of $60. The price of the stock has decreased by 1% since.
- EVP, Chief Scientific Officer C Frank Bennett sold 15,000 shares of IONS stock on 06/25/2020 at the average price of $59.77. The price of the stock has decreased by 0.62% since.
- Exec Chairman of the Board Stanley T Crooke sold 14,914 shares of IONS stock on 06/25/2020 at the average price of $59.67. The price of the stock has decreased by 0.45% since.
- Director Spencer R Berthelsen sold 15,000 shares of IONS stock on 06/23/2020 at the average price of $58.76. The price of the stock has increased by 1.09% since.
- Exec Chairman of the Board Stanley T Crooke sold 27,000 shares of IONS stock on 06/19/2020 at the average price of $58.08. The price of the stock has increased by 2.27% since.
For the complete insider trading history of IONS, click here
.
